| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |